Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease
Abyadeh, M, Gupta, V, Gupta, V, Chitranshi, N, Wu, Y, Amirkhani, A, Meyfour, A, Sheriff, S, Shen, T, Dhiman, Kunal, Salekdeh, GH, Haynes, PA, Graham, SL and Mirzaei, M 2021, Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease, Aging and Disease, vol. 12, no. 8, pp. 1964-1976, doi: 10.14336/AD.2021.0719.
Attached Files
Name
Description
MIMEType
Size
Downloads
Title
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease
Unless expressly stated otherwise, the copyright for items in DRO is owned by the author, with all rights reserved.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO.
If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.
Every reasonable effort has been made to ensure that permission has been obtained for items included in DRO. If you believe that your rights have been infringed by this repository, please contact drosupport@deakin.edu.au.